BioSpace News Archive

CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today reported its financial results for the first quarter ended March 31, 2024.

Immutep Limited today announces encouraging efficacy, safety, and pharmacodynamic data from the safety lead-in of the AIPAC-003 Phase II/III trial presented at the European Society for Medical Oncology (ESMO) Breast Cancer 2024 Congress.

Intensity Therapeutics, Inc. announces the appointment of Thomas Dubin, J.D., MPH, to the Intensity Board of Directors, effective May 14, 2024.

TriSalus Life Sciences Inc., announced its financial results for the first quarter ended March 31, 2024, and provided a business update.

The closing of the offering is expected to occur on or about May 17, 2024, subject to the satisfaction of customary closing conditions.

AtriCure, Inc. today announced that the company will be participating in the upcoming Leerink Partners Healthcare Crossroads Conference.

Infinimmune announced today the appointment of a new independent director, Neela Patel, Ph.D., to the company’s Board of Directors.

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, has appointed Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations to support the commercialization of ColoSense, which recently received FDA approval for colorectal cancer screening in average-risk individuals over 45 years of age.

Veru Inc. announced Steven B. Heymsfield, M.D., a Professor and the Director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, as the Principal Investigator for the Company’s Phase 2b clinical trial of enobosarm to preserve muscle while augmenting fat loss in patients receiving a GLP-1 RA for weight loss.

Yield10 Bioscience, Inc., an agricultural bioscience company, announced that Company has received a final delisting notice from Nasdaq.